16-18 July 2018 | Boston

Register interest for 2019 and the event series 

TM Boston Header

Secure Your Place
Find Out More

The 6th Annual Tumor Models Boston Conference

For the last 6 years the Tumor Models Conference has sat at the interface of innovation in model development and therapeutic application.

It continues to serve as an open and collaborative platform enabling pharmaceutical scientists, model developers and academicians to explore recent advances in the range of in-vitro and in-vivo systems.

The meeting will once again delve into how these models are successfully being utilized for discovery, safety assessment and to enhance confidence in clinical translation of cancer research.

What’s New For 2018:

symbol logo New insights into how preclinical models are being utilized to better understand the fundamental role of the TME in altering drug response, efficacy and metabolism
symbol logo A spotlight on how the industry has been selecting and characterizing models to optimize their application in preclinical and translational decision process
symbol logo Greater focus on rationally modeling next-generation combination therapies to overcome sensitivity and resistance
symbol logo A greater exploration of how new technologies are bridging the In Vitro- In Vivo gap to incorporate tissue/patient level responses

Why Is This Event For You?

Media Partner